Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darin K Edwards

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
The Lancet. Infectious Diseases|July 10, 2025
Efficacy, immunogenicity, and safety of a next-generation mRNA-1283 COVID-19 vaccine compared with the mRNA-1273 vaccine (NextCOVE): results from a phase 3, randomised, observer-blind, active-controlled trialSpyros Chalkias, Patrick Dennis, Dena Petersen, et al.
Nature Medicine|September 16, 2021
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysisAngela Choi, Matthew Koch, Kai Wu, et al.
Nature Communications|December 2, 2023
Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primatesChaim A Schramm, Damee Moon, Lowrey Peyton, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in miceBaoling Ying, Suzanne M Scheaffer, Bradley Whitener, et al.
Nature Medicine|August 31, 2023
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim resultsSpyros Chalkias, Jordan L Whatley, Frank Eder, et al.
Science Advances|September 22, 2023
Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infectionGabriela Baldeon Vaca, Michelle Meyer, Ana Cadete, et al.
Science Translational Medicine|November 30, 2021
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strainsBaoling Ying, Bradley Whitener, Laura A VanBlargan, et al.
Biorxiv : the Preprint Server for Biology|August 31, 2021
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strainsBaoling Ying, Bradley Whitener, Laura A VanBlargan, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccinesSandhya Bangaru, Abigail M Jackson, Jeffrey Copps, et al.
Vaccine|November 24, 2021
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in miceKai Wu, Angela Choi, Matthew Koch, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
The Lancet. Infectious Diseases|July 10, 2025
Efficacy, immunogenicity, and safety of a next-generation mRNA-1283 COVID-19 vaccine compared with the mRNA-1273 vaccine (NextCOVE): results from a phase 3, randomised, observer-blind, active-controlled trialSpyros Chalkias, Patrick Dennis, Dena Petersen, et al.
Nature Medicine|September 16, 2021
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysisAngela Choi, Matthew Koch, Kai Wu, et al.
Nature Communications|December 2, 2023
Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primatesChaim A Schramm, Damee Moon, Lowrey Peyton, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in miceBaoling Ying, Suzanne M Scheaffer, Bradley Whitener, et al.
Nature Medicine|August 31, 2023
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim resultsSpyros Chalkias, Jordan L Whatley, Frank Eder, et al.
Science Advances|September 22, 2023
Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infectionGabriela Baldeon Vaca, Michelle Meyer, Ana Cadete, et al.
Science Translational Medicine|November 30, 2021
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strainsBaoling Ying, Bradley Whitener, Laura A VanBlargan, et al.
Biorxiv : the Preprint Server for Biology|August 31, 2021
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strainsBaoling Ying, Bradley Whitener, Laura A VanBlargan, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccinesSandhya Bangaru, Abigail M Jackson, Jeffrey Copps, et al.
Vaccine|November 24, 2021
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in miceKai Wu, Angela Choi, Matthew Koch, et al.
Pageof 6